Epigenetics in mood disorders
Authors:
- 11 December 2007
- journal article
- special feature
- Published by Springer Nature in Environmental Health and Preventive Medicine
- Vol. 13 (1) , 16-24
Abstract
Depression develops as an interaction between stress and an individual’s vulnerability to stress. The effect of early life stress and a gene–environment interaction may play a role in the development of stress vulnerability as a risk factor for depression. The epigenetic regulation of the promoter of the glucocorticoid receptor gene has been suggested as a molecular basis of such stress vulnerability. It has also been suggested that antidepressive treatment, such as antidepressant medication and electroconvulsive therapy, may be mediated by histone modification on the promoter of the brain-derived neurotrophic factor gene. Clinical genetic studies in bipolar disorder suggest the role of genomic imprinting, although no direct molecular evidence of this has been reported. The role of DNA methylation in mood regulation is indicated by the antimanic effect of valproate, a histone deacetylase inhibitor, and the antidepressive effect of S-adenosyl methionine, a methyl donor in DNA methylation. Studies of postmortem brains of patients have implicated altered DNA meA methylation of the promoter region of membrane-bound catechol-O-methyltransferase in bipolar disorder. An altered DNA methylation status of PPIEL (peptidylprolyl isomerase E-like) was found in a pair of monozygotic twins discordant for bipolar disorder. Hypomethylation of PPIEL was also found in patients with bipolar II disorder in a case control analysis. These fragmentary findings suggest the possible role of epigenetics in mood disorders. Further studies of epigenetics in mood disorders are warranted.Keywords
This publication has 88 references indexed in Scilit:
- Neural correlates of epigenesisProceedings of the National Academy of Sciences, 2006
- Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorderHuman Molecular Genetics, 2006
- Histone H3 Lysine 4 Demethylation Is a Target of Nonselective Antidepressive MedicationsChemistry & Biology, 2006
- Functional polymorphisms of HSPA5: Possible association with bipolar disorderBiochemical and Biophysical Research Communications, 2005
- Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2005
- X-box binding protein 1 (XBP1) C−116G polymorphisms in bipolar disorders and age of onsetNeuroscience Letters, 2004
- Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neuronsThe Pharmacogenomics Journal, 2004
- Epigenetic programming by maternal behaviorNature Neuroscience, 2004
- Dopamine D4 receptor and tyrosine hydroxylase genes in bipolar disorder: evidence for a role of DRD4Molecular Psychiatry, 2002
- Translating the Histone CodeScience, 2001